Stock Markets Analysis & Opinion

Shares of Church & Dwight Co., Inc. (NYSE:CHD) touched a new 52 week high of $53.79 on Jun 19, to close at $53.75.We note that company’s shares have been gaining momentum for the last...

Shares of TripAdvisor, Inc. (NASDAQ:TRIP) hit a 52-week low of $36.10 on Jun 19.The stock has declined 23.1% since its first-quarter 2017 results on May 9 against the Zacks Electronic Commerce...

Just days after Amazon’s (NASDAQ:AMZN) buzzworthy announcement that it is acquiring organic grocery chain Whole Foods Market (NASDAQ:WFM) , the e-commerce giant has unveiled a new tier to its...

Shares of Chipotle Mexican Grill (NYSE:CMG) fell more than 6.5% in morning trading Tuesday after the company announced updated guidance for the remainder of the fiscal year. Investors are reacting...

U.S. stocks began the week with solid gains as technology issues led a broad based advance that pushed the Dow and S&P to fresh record highs, while the NASDAQ saw the largest percentage gain for...

At Zacks, we want our customers to profit from certain stocks and industries that are currently surging. The transportation sector, specifically the airline industry, has been soaring high recently....

Short term DAX Elliott Wave view suggests the decline to 12491.5 on 5/18 ended Intermediate wave (2). Up from there, the rally is unfolding as a double three Elliott Wave structure. Minute wave ((w))...

Emerging market (EM) ETFs have had a great run in the last one year (as of June 19, 2017) with iShares MSCI Emerging Markets EEM returning over 24%. This year, the segment is doing well on improving...

Johnson & Johnson (NYSE:JNJ) announced a three-year follow-up data from a late stage study, evaluating its cancer drug Imbruvica (ibrutinib) against Pfizer Inc.’s (NYSE:PFE) Torisel...

London-based pharma giant, AstraZeneca plc (NYSE:AZN) has a strong product portfolio and is one of the key players in the global cardiovascular market.AstraZeneca carries a Zacks Rank #2 (Buy). You...

Horizon Pharma plc (NASDAQ:HZNP) , announced that it has received approval in Canada for Procysbi (cysteamine delayed-release capsules) for the treatment of nephropathic cystinosis in adults and...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced that the FDA has accepted its new drug application (NDA) seeking approval for its oral spleen tyrosine kinase inhibitor, fostamatinib for the...

Amgen Inc. (NASDAQ:AMGN) announced that the FDA has accepted its supplemental Biologics License Application (sBLA) to expand the label of its key drug, Xgeva.Xgeva is currently approved for the...

International Business Machines Corp. (NYSE:IBM) recently won a contract from Australia-based Acrow to refresh the latter's IT infrastructure. Per the terms of the agreement, Acrow’s existing...